Page 21 - Collaborating Centre News Today : Breaking News, Live Updates & Top Stories | Vimarsana

An outbreak of avian influenza (HPAI) H5N1 has been reported on 30 farms across seven states in Nigeria, according to the Nigeria Centre for Disease Control (NCDC)

Abu Dhabi: Mubadala Health’s Imperial College London Diabetes Centre (ICLDC) has become the first such facility in Abu Dhabi and the third in the UAE to be accredited as a Collaborating Centre for Obesity Management (COM) by the European Association for the Study of Obesity (EASO). Under the EASO COM scheme, obesity management centres are accredited against a set of stringent criteria and in accordance with accepted European and academic guidelines to ensure consistently high standards in different countries across the world. The EASO Obesity Management Task Force completed its assessment o...

Related Pages Continuing safe yellow fever vaccination efforts are critical during the COVID-19 pandemic. A yellow fever outbreak amidst a pandemic would devastate already strained healthcare systems and lead to unnecessary lives lost. CDC, CDC Foundation, and their partners have been critical to ensuring public health professionals and vaccine recipients have access to resources needed to continue the global fight against yellow fever while reducing the risk of COVID-19. CDC works globally to combat the threat of mosquito-borne diseases, including yellow fever which kills an estimated 30,000...

Photo story - Primary health care advanced in Armenia as WHO assists with improving guidelines WHO, with funding from the European Union, is assisting Armenia’s Ministry of Health (MoH) in adapting and improving guidelines on the management and treatment of a variety of infections, including community-acquired pneumonia, pharyngitis, urinary tract infections, otitis media, as well as COVID-19. WHO is helping introduce these guidelines to primary health care providers throughout the country. Primary health care (PHC) addresses most of a person’s health care needs throughout their lifetime,...

Follow RT on The third Covid-19 vaccine registered in Russia is based on a “perfectly conventional” platform, and those who have been injected experienced no side effects, the head of the Chumakov Scientific Center, which created it, told RT. The CoviVac vaccine received national approval in Russia on February 20. The first batch of doses is expected to be available to the public in mid-March, according to the government. The vaccine is based on the most traditional technology that has been around for a long time and is widely used throughout the world, Aidar Ishmukhametov, the di...